Exhibit 32.1

CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350, AS
ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The certification set forth below is hereby made solely for
the purpose of satisfying the requirements of Section 906 of
the Sarbanes-Oxley Act of 2002 and may not be relied upon or
used for any other purposes.

In connection with the Quarterly Report of Access
Pharmaceuticals, Inc. (the "Company") on Form 10-Q/A for the
period ended September 30, 2003, as filed with the
Securities and Exchange Commission on the date hereof (the
"Report"), I, Kerry P. Gray, President and Chief Executive
Officer, certify pursuant to 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that to my knowledge

(1) the Report fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of
1934; and

(2) the information contained in the Report fairly presents,
in all material respects, the financial condition and
results of operations of the Company.

A signed original of this written statement required by
Section 906 or other document authenticating, acknowledging
or otherwise adopting the signature that appears in typed
form within the electronic version of this written statement
required by Section 906 has been provided to the Company and
will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon
request.

Date: February 5, 2004

/s/ Kerry P. Gray
- -----------------
Kerry P. Gray
President and Chief Executive Officer